glp-1 vs compounded semaglutide What's the Difference Between Brand-Name and GLP-1 for Weight Loss? How to Safely Switch from

At one year, patients with moderate PAD who were started on GLP-1 RAs had fewer major adverse limb events (MALE) (0.8% vs 1.5%), major adverse cardiac events (MACE) (25.4% vs 29.3%), and decreased risk of hospitalizations (17.9 vs 26.8%)

Conditions such as atrophic gastritis (thinning of the stomach lining), Pernicious anemia (which makes it harder for your body to absorb Vitamin B12), Intestinal diseases such as crohns disease, celiac disease, bacterial growth and immune system disorders such as Graves disease or lupus can lead to Vitamin B12 deficiency in the body

The result may be an increased appetite and tendency to regain weight

By August 2025, research from the RAND American Life Panel showed that approximately 11.8% of American adults (nearly 1 in 8 people) had used GLP-1 medications at least once, marking a dramatic increase in adoption